CynergisTek, Inc. (NYSE AMERICAN: CTEK), a leader in cybersecurity, privacy, and compliance, today announced that it has appointed Tony Douglas as its senior vice president of sales. In this role, Douglas will build and lead CynergisTek’s business development and sales strategy. Douglas brings to the team nearly two decades of proven sales achievements and technical leadership in both the healthcare IT and security industries.
Prior to joining CynergisTek, Douglas held multiple leadership positions at Symantec Corporation, a Fortune 500 information security software and services provider, most recently leading as its vice president of healthcare sales. During his tenure, he played an increasingly integral role in developing and executing on the go-to-market strategy for the healthcare business, which consistently delivered double-digit growth and routinely exceeded the annual plan. Prior to Symantec Corporation, Douglas held technical, project management, and commercial roles at organizations including McKesson Provider Technologies and Carestream Health.
“I am passionate about the intersection between security and healthcare and I believe that we need to give patients the same level of trust and confidence with their data as they have with their clinicians,” said Douglas. “When the opportunity arose to join one of the top security and privacy firms in the healthcare, I was all in.”
“As we looked for a sales leader that could lead the next phase of CynergisTek’s revenue growth, we wanted to find someone that could swim in three lanes – an accomplished salesperson, a security professional, and a leader with the contacts, reputation, and knowledge of the healthcare industry," said Caleb Barlow, CEO of CynergisTek. “Douglas can swim in all three lanes and he has a proven track record of growing revenue and building sales teams that can scale.”
Douglas’s hire comes on the heels of the recent appointment of Benjamin Denkers, senior vice president of security and privacy services, and the acquisition of Backbone Consultants with their three partners - Nikhil D'Souza, Jacob Carroll, and Walter Zuniga.
About CynergisTek, Inc.
CynergisTek is a top-ranked cybersecurity firm dedicated to serving the information assurance needs of the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security, and compliance goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been recognized by KLAS as a top performing firm in healthcare cybersecurity and was awarded the 2019 Top Healthcare Cybersecurity Consults in Black Book IT Advisory Outcomes Survey.
This release contains certain forward-looking statements relating to the business of CynergisTek that can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “may” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product/service development, long and uncertain sales cycles, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, future capital requirements, competition from other providers, the ability of our vendors to continue supplying the company with equipment, parts, supplies and services at comparable terms and prices and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.